CNXC
Concentrix Corporation
CNXC has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CNXC overall, supported by stronger fundamentals and stronger modeled upside.
CNXC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Under pressure |
CNXC's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CNXC PE Valuation
CNXC has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
CNXC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect CNXC's earnings to grow and its profitability to improve, with its revenue holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over CNXC on the outlook, with more favorable revenue expectations.
CNXC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.51 | — |
| Q3 2026 | -$38.42 | -912% |
| Q2 2026 | -$20.84 | -673% |
| Q1 2026 | -$21.07 | -628% |
| Q4 2025 | -$20.36 | -649% |
| Q3 2025 | $4.73 | +57% |
| Q2 2025 | $3.64 | -14% |
| Q1 2025 | $3.99 | -17% |
| Q4 2024 | $3.71 | -35% |
CNXC has swung to a loss: it lost $38.42 per share over the past year, after a profit the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CNXC in the latest year-over-year earnings comparison.
CNXC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.5B | -1.2% |
| Q2 2026 | $2.5B | +1.9% |
| Q1 2026 | $2.5B | +5.4% |
| Q4 2025 | $2.6B | +4.3% |
| Q3 2025 | $2.5B | +4% |
| Q2 2025 | $2.4B | +1.5% |
| Q1 2025 | $2.4B | -1.3% |
| Q4 2024 | $2.4B | +9.7% |
CNXC's revenue grew through 2024 and has held roughly level since: $2.5B last quarter, down 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -37% | -43 points |
| Q2 2026 | 3.9% | -2.3 points |
| Q1 2026 | 4.7% | -2.4 points |
| Q4 2025 | -54% | -60 points |
| Q3 2025 | 5.9% | -0.5 points |
| Q2 2025 | 6.1% | -0.2 points |
| Q1 2025 | 7.1% | +0.9 points |
| Q4 2024 | 5.9% | -2.2 points |
CNXC's operating margin was −37% last quarter, down 43 points from the same quarter a year ago, near the bottom of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over CNXC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CNXC on profitability, with a higher operating margin.
CNXC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $221.2M | +38% |
| Q2 2026 | $209.7M | +16% |
| Q1 2026 | -$137.1M | -$87.9M |
| Q4 2025 | $281.2M | +25% |
| Q3 2025 | $159.7M | +24% |
| Q2 2025 | $180.7M | +1.4% |
| Q1 2025 | -$49.2M | +$53.7M |
| Q4 2024 | $224.5M | +37% |
CNXC generated $575M in free cash flow over the past year, up 11% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
CNXC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.2x | High |
| Q3 2024 | 4.7x | High |
| Q2 2024 | 5.4x | High |
| Q1 2024 | 5.6x | High |
| Q4 2023 | 5.6x | High |
CNXC's net debt is about 3.5 years of its operating earnings (EBITDA), down from 4.7 years a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CNXC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.3 | Neutral |
| Stochastic | 68.9 | Neutral |
CNXC's weekly RSI is 56 (neutral) and its Stochastic is 69 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CNXC PE vs Technology Sector
| Metric | CNXC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CNXC has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
CNXC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.9 | 11% above |
| 20 week MA | $27.1 | 18% above |
| 50 week MA | $30.3 | 5.7% above |
| 100 week MA | $39.7 | 19% below |
| 200 week MA | $60.0 | 47% below |
CNXC has stronger trend alignment. CNXC is above 3 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CNXC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.0 | $99.9 | +25% |
| 2021 | $99.9 | $177.2 | +77% |
| 2022 | $177.2 | $129.6 | -27% |
| 2023 | $129.6 | $98.2 | -24% |
| 2024 | $98.2 | $44.4 | -55% |
| 2025 | $44.4 | $42.0 | -5.6% |
| 2026 YTD | $42.0 | $32.0 | -24% |
CNXC has finished four years in a row lower, and it's down 24% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CNXC on returns for 2026, with the stronger performance.